New multiple action intestinal hormone corrects diabetes
Wednesday, October 30, 2013 - 14:00
in Health & Medicine
Scientists have developed a new therapeutic approach for treatment of Type 2 diabetes. A novel single molecule hormone, which acts equally on the receptors of the insulin-stimulating hormones GLP-1 and GIP, was observed to reduce weight and improve blood sugar.